Search research articles
Contact Us
Filters
Showing results (471-480 of 488) with videos related to
Page
of 49
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones
S H Jung, H S Lee, J S Song, et al.
Journal of Korean Medical Science
|
October 20, 2001
Clinical characteristics of constrictive pericarditis diagnosed by echo-Doppler technique in Korea
H S Yang, J K Song, J M Song, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
January 14, 2025
Efficacy and safety of home-based transcranial direct current stimulation as adjunct treatment for cognitive improvement in major depressive disorder: A double-blind, randomized, multi-site clinical trial
C W Lee, K Park, J E Ahn, et al.
Journal of the Endocrine Society
|
December 12, 2018
Targeting Semaphorin 3C in Prostate Cancer With Small Molecules
Chung C W Lee, Ravi Shashi Nayana Munuganti, James W Peacock, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
ESMO Open
|
December 6, 2024
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial
T K Choueiri, T M Kuzel, S S Tykodi, et al.
Cancers
|
March 28, 2026
End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta
Evelyn R Lu, Calvin P L Hoo, Ho Ming Cheung, et al.
American Journal of Hematology
|
February 13, 2008
Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong Kong
Geoffrey T Gibney, Carolien I M Panhuysen, Jason C C So, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2026
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial
T K Choueiri, L Albigès, D F McDermott, et al.
International Orthopaedics
|
March 1, 2018
Three-in-one protocol reduces mortality of patients with haemodynamically unstable pelvic fractures-a five year multi-centred review in Hong Kong
Mina Cheng, Kin-Yan Lee, Annice-M L Chang, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 488) with videos related to
Sort By:
Page
of 49
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones
S H Jung, H S Lee, J S Song, et al.
Journal of Korean Medical Science
|
October 20, 2001
Clinical characteristics of constrictive pericarditis diagnosed by echo-Doppler technique in Korea
H S Yang, J K Song, J M Song, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
January 14, 2025
Efficacy and safety of home-based transcranial direct current stimulation as adjunct treatment for cognitive improvement in major depressive disorder: A double-blind, randomized, multi-site clinical trial
C W Lee, K Park, J E Ahn, et al.
Journal of the Endocrine Society
|
December 12, 2018
Targeting Semaphorin 3C in Prostate Cancer With Small Molecules
Chung C W Lee, Ravi Shashi Nayana Munuganti, James W Peacock, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
ESMO Open
|
December 6, 2024
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial
T K Choueiri, T M Kuzel, S S Tykodi, et al.
Cancers
|
March 28, 2026
End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta
Evelyn R Lu, Calvin P L Hoo, Ho Ming Cheung, et al.
American Journal of Hematology
|
February 13, 2008
Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong Kong
Geoffrey T Gibney, Carolien I M Panhuysen, Jason C C So, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2026
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial
T K Choueiri, L Albigès, D F McDermott, et al.
International Orthopaedics
|
March 1, 2018
Three-in-one protocol reduces mortality of patients with haemodynamically unstable pelvic fractures-a five year multi-centred review in Hong Kong
Mina Cheng, Kin-Yan Lee, Annice-M L Chang, et al.
Page
of 49